The Statistics and Bioinformatics Core (SBC) of the Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) will assist in the design of optimal metabolomic experiments and transform measurements produced by the Analytical and Data and Information Technology Cores into information and knowledge that will enhance the research of the Core user. To accomplish these goals, the SBC will benefit from its close association with the Department of Computational Medicine and Bioinformatics and its National Center for Integrative Biomedical Informatics (NCIBI). Specifically, the SBC will assist MRC2 users in the design of metabolomics studies in cells, tissues and biofluids. Following analysis, the Core will provide the Core user with data sets from directed metabolomics measures that have been evaluated for quality and with information of the estimated errors for the measurement of the metabolites. The Core will develop and apply statistical methods and tools to accurately define levels of metabolites and compare treatment effects in untargeted metabolomic analysis and provide individualized statistical tools for analysis of metabolomics data for Core users. To better obtain information about individual metabolites of interest the SBC will provide bioinformatics tools, such as Metab2Mesh and Metscape to provide insights into the metabolites and to visualize individual and groups of metabolites In metabolic pathways. Using these, and other tools, SBC personnel will work with investigators to develop appropriate procedures for multi-scale integration of phenotypic and metabolomic data. Working with the Promotion and Outreach Core and the NCIBI, investigators will be trained in the methodologies related to Laboratory Information Management System (LIMS) utilization, spectral interpretation, data management, and data conversions. To increase the pool of metabolomics investigators, the Core will train graduate students in the technologies essential for metabolomics biostatistical and bioinformatic data analysis. Finally, the SBC will provide new tools and techniques to other Regional Comprehensive Metabolomics Resource Cores (RCMRCs) to enhance their ability to provide services to Core customers for metabolomic analysis.
Data generated from metabolomics analysis need to be carefully evaluated to obtain the inherent information in the data sets. Statistical methodology can be utilized to improve the recognition of changes in metabolites in disease states and bioinformatics technologies can be used to better visualize the pathways containing metabolites of interest and to integrate them with other information to understand the disease pathogenesis and responses to treatment.
|Puskarich, Michael A; Evans, Charles R; Karnovsky, Alla et al. (2018) Septic Shock Nonsurvivors Have Persistently Elevated Acylcarnitines Following Carnitine Supplementation. Shock 49:412-419|
|Schofield, Heather K; Zeller, Jörg; Espinoza, Carlos et al. (2018) Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma. JCI Insight 3:|
|Gok, Emre; Alghanem, Fares; Moon, Ruth et al. (2018) Development of an Ex-Situ Limb Perfusion System for a Rodent Model. ASAIO J :|
|Bria, Carmen R M; Afshinnia, Farsad; Skelly, Patrick W et al. (2018) Asymmetrical flow field-flow fractionation for improved characterization of human plasma lipoproteins. Anal Bioanal Chem :|
|Maile, Michael D; Standiford, Theodore J; Engoren, Milo C et al. (2018) Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study. Respir Res 19:60|
|Perng, Wei; Tang, Lu; Song, Peter X K et al. (2018) Metabolomic profiles and development of metabolic risk during the pubertal transition: a prospective study in the ELEMENT Project. Pediatr Res :|
|Zarrinpar, Amir; Chaix, Amandine; Xu, Zhenjiang Z et al. (2018) Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat Commun 9:2872|
|Ward, Kristen M; Yeoman, Larisa; McHugh, Cora et al. (2018) Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia. Pharmacotherapy 38:638-650|
|Jadoon, Adil; Mathew, Anna V; Byun, Jaeman et al. (2018) Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients. Am J Nephrol 48:269-277|
|Patel, Anita; Yusta, Bernardo; Matthews, Dianne et al. (2018) GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr-/- mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy. Mol Metab 16:45-54|
Showing the most recent 10 out of 139 publications